Cytokinetics
CYTK
CYTK
240 hedge funds and large institutions have $3.4B invested in Cytokinetics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 99 increasing their positions, 86 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $3.99B → $3.4B (-$595M)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
Holders
240
Holding in Top 10
8
Calls
$12.7M
Puts
$5.41M
Top Buyers
| 1 | +$62.2M | |
| 2 | +$51.4M | |
| 3 | +$50.6M | |
| 4 |
HM
HealthCor Management
New York
|
+$37M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$26.2M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$17.8M | |
| 3 | -$17.4M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$15.6M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$14.3M |